Market Place
Sourcing Support
Endevica Bio Spins Off New Company to Develop Weight Loss Drug
01 Nov 2024 //
PR NEWSWIRE
Endevica Bio drug candidate shows success in weight loss in new study
23 Apr 2024 //
PR NEWSWIRE
Orbit and Endevica Enter Collaboration for Cachexia Therapeutics
01 Feb 2023 //
BUSINESSWIRE
Endevica Reports Positive TCMCB07 Data from Phase 1 Trial in Cachexia
15 Nov 2022 //
BUSINESSWIRE
Endevica Bio Begins Dosing in PI Trial of TCMCB07 for Cachexia
13 Jul 2022 //
BUSINESSWIRE
Endevica Reports the U.S. FDA Accepted Its IND Application for TCMCB07
28 Jun 2022 //
BUSINESSWIRE
Endevica Bio Appoints Prominent Cachexia Physician, Daniel Marks MD, PhD, as CMO
16 May 2022 //
BUSINESSWIRE
New Data on Endevica Bio’s Lead Compound, TCMCB07
20 Apr 2022 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.